Valvular heart disease
Conditions
Interventions
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 3-5 days after TAVR; 2. Qi and Blood Deficiency and Stasis Blocking Water Stopping Syndrome; 3. Subjects were informed and voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Severe postoperative complications: acute heart failure, myocardial infarction, III degree atrioventricular block, and other malignant arrhythmias, aortic dissection; 2. Liver dysfunction (ALT or AST level is 2 times higher than normal value) and renal impairment (serum creatinine level is 2 times higher than normal value); 3. Patients with specific bleeding history or bleeding history due to warfarin use; 4. Patients taking other Chinese medicines within 90 days; 5. Anaphylaxis with known or suspected ingredients in Chinese herbal prescriptions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Six minute walk test; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score;Comprehensive geriatric assessment;physicochemical indexes; | — |
Countries
China
Contacts
Public ContactChen Keji
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed